A REDUCTION IN C-SECTION RATES USING THE HEM-AVERT® PERIANAL STABILIZER.

This study is being conducted to evaluate an existing FDA approved device called the HEM-AVERT® Perianal Stabilizer for its efficacy in reducing Cesarean births and/or reducing the second stage of labor.

Inclusion Criteria:

• Subject is scheduled for vaginal delivery.
• Subject is willing and able to comply with the study plan as indicated by understanding and signing the Subject Informed Consent Form.
• Subjects' pre-natal examination indicates that this is to be a single birth delivery.

Exclusion Criteria:

• Subject's scheduled for vaginal delivery with anticipated complications.
• Subject is unable to understand and sign the informed consent form.
• Subject does not deliver at study facility (hospital).